Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Novel clinically relevant antibiotic resistance genes associated with sewage sludge and industrial waste streams revealed by functional metagenomic screening.

Zhang L, Calvo-Bado L, Murray AK, Amos GCA, Hawkey PM, Wellington EM, Gaze WH.

Environ Int. 2019 Nov;132:105120. doi: 10.1016/j.envint.2019.105120. Epub 2019 Sep 2.

2.

Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11.

Vynnycky E, Keen AR, Evans JT, Khanom S, Hawkey PM, White RG, Abubakar I.

BMC Infect Dis. 2019 Jan 7;19(1):26. doi: 10.1186/s12879-018-3585-8.

3.

Acquisition and Loss of CTX-M-Producing and Non-Producing Escherichia coli in the Fecal Microbiome of Travelers to South Asia.

Bevan ER, McNally A, Thomas CM, Piddock LJV, Hawkey PM.

MBio. 2018 Dec 11;9(6). pii: e02408-18. doi: 10.1128/mBio.02408-18.

4.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD.

J Hosp Infect. 2018 Sep;100 Suppl 1:S1-S31. doi: 10.1016/j.jhin.2018.07.037. No abstract available.

5.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT.

Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.

6.

The 2017 Garrod Lecture: Genes, guts and globalization.

Hawkey PM.

J Antimicrob Chemother. 2018 Oct 1;73(10):2589-2600. doi: 10.1093/jac/dky277.

PMID:
30085107
7.

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.

Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR.

J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. Review.

PMID:
29514274
8.

CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014.

McNulty CAM, Lecky DM, Xu-McCrae L, Nakiboneka-Ssenabulya D, Chung KT, Nichols T, Thomas HL, Thomas M, Alvarez-Buylla A, Turner K, Shabir S, Manzoor S, Smith S, Crocker L, Hawkey PM.

J Antimicrob Chemother. 2018 May 1;73(5):1368-1388. doi: 10.1093/jac/dky007.

9.

The widespread dissemination of integrons throughout bacterial communities in a riverine system.

Amos GCA, Ploumakis S, Zhang L, Hawkey PM, Gaze WH, Wellington EMH.

ISME J. 2018 Mar;12(3):681-691. doi: 10.1038/s41396-017-0030-8. Epub 2018 Jan 26.

10.

Exposure to and colonisation by antibiotic-resistant E. coli in UK coastal water users: Environmental surveillance, exposure assessment, and epidemiological study (Beach Bum Survey).

Leonard AFC, Zhang L, Balfour AJ, Garside R, Hawkey PM, Murray AK, Ukoumunne OC, Gaze WH.

Environ Int. 2018 May;114:326-333. doi: 10.1016/j.envint.2017.11.003. Epub 2018 Jan 14.

11.

Effect of general practice characteristics and antibiotic prescribing on Escherichia coli antibiotic non-susceptibility in the West Midlands region of England: a 4 year ecological study.

Ironmonger D, Edeghere O, Verlander NQ, Gossain S, Hopkins S, Hilton B, Hawkey PM.

J Antimicrob Chemother. 2018 Mar 1;73(3):787-794. doi: 10.1093/jac/dkx465.

PMID:
29309593
12.

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).

Woodford N, Xu-McCrae L, Mushtaq S, Wu HHT, Ellington MJ, Lancaster O, Davies F, Donaldson H, Rao GG, Verma A, Wareham DW, Ciesielczuk H, Stone GG, Irani PM, Bracher S, Hawkey PM.

J Antimicrob Chemother. 2018 Mar 1;73(3):698-702. doi: 10.1093/jac/dkx471.

PMID:
29253163
13.

Community-acquired pneumonia in the United Kingdom: a call to action.

Chalmers J, Campling J, Ellsbury G, Hawkey PM, Madhava H, Slack M.

Pneumonia (Nathan). 2017 Oct 5;9:15. doi: 10.1186/s41479-017-0039-9. eCollection 2017.

14.

Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014.

Ho J, Dai RZW, Kwong TNY, Wang X, Zhang L, Ip M, Chan R, Hawkey PMK, Lam KLY, Wong MCS, Tse G, Chan MTV, Chan FKL, Yu J, Ng SC, Lee N, Wu JCY, Sung JJY, Wu WKK, Wong SH.

Emerg Infect Dis. 2017 Oct;23(10):1671-1679. doi: 10.3201/eid2310.170797.

15.

Investigation of community carriage rates of Clostridium difficile and Hungatella hathewayi in healthy volunteers from four regions of England.

Manzoor SE, McNulty CAM, Nakiboneka-Ssenabulya D, Lecky DM, Hardy KJ, Hawkey PM.

J Hosp Infect. 2017 Oct;97(2):153-155. doi: 10.1016/j.jhin.2017.05.014. Epub 2017 May 23.

PMID:
28549779
16.

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.

Bevan ER, Jones AM, Hawkey PM.

J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155. doi: 10.1093/jac/dkx146. Review.

PMID:
28541467
17.

Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages".

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Jun;55(6):1971. doi: 10.1128/JCM.00487-17. No abstract available.

18.

Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.

Rosello A, Hayward AC, Hopkins S, Horner C, Ironmonger D, Hawkey PM, Deeny SR.

J Antimicrob Chemother. 2017 Apr 1;72(4):1184-1192. doi: 10.1093/jac/dkw555.

PMID:
28077671
19.

Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.

Findlay J, Hopkins KL, Alvarez-Buylla A, Meunier D, Mustafa N, Hill R, Pike R, McCrae LX, Hawkey PM, Woodford N.

J Antimicrob Chemother. 2017 Apr 1;72(4):1054-1062. doi: 10.1093/jac/dkw560.

PMID:
28073969
20.

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Mar;55(3):865-876. doi: 10.1128/JCM.01296-16. Epub 2016 Dec 28. Erratum in: J Clin Microbiol. 2017 Jun;55(6):1971.

21.
22.

Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.

Munang ML, Browne C, Evans JT, Smith EG, Hawkey PM, Welch SB, Kaur H, Dedicoat MJ.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1300-1305.

PMID:
27725038
23.

Genome and Plasmid Analysis of blaIMP-4-Carrying Citrobacter freundii B38.

Xiong J, Déraspe M, Iqbal N, Ma J, Jamieson FB, Wasserscheid J, Dewar K, Hawkey PM, Roy PH.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6719-6725. doi: 10.1128/AAC.00588-16. Print 2016 Nov.

24.

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts.

Freeman R, Ironmonger D, Puleston R, Hopkins KL, Welfare W, Hope R, Staves P, Shemko M, Hopkins S, Cleary P, Patel B, Muller-Pebody B, Li X, Alvarez-Buylla A, Hawkey PM, Johnson AP, Woodford N, Oliver I.

Clin Microbiol Infect. 2016 Oct;22(10):896-897. doi: 10.1016/j.cmi.2016.07.020. Epub 2016 Jul 27. No abstract available.

25.

High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.

Wong SH, Ip M, Hawkey PM, Lo N, Hardy K, Manzoor S, Hui WW, Choi KW, Wong RY, Yung IM, Cheung CS, Lam KL, Kwong T, Wu WK, Ng SC, Wu JC, Sung JJ, Lee N.

J Infect. 2016 Aug;73(2):115-22. doi: 10.1016/j.jinf.2016.05.010. Epub 2016 May 28.

PMID:
27246801
26.
27.

Antibiotic surgical prophylaxis increases nasal carriage of antibiotic-resistant staphylococci.

McMurray CL, Hardy KJ, Verlander NQ, Hawkey PM.

J Med Microbiol. 2015 Dec;64(12):1489-95. doi: 10.1099/jmm.0.000182. Epub 2015 Oct 6.

PMID:
26445858
28.

Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.

Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM.

J Antimicrob Chemother. 2015 Aug;70(8):2223-7. doi: 10.1093/jac/dkv114. Epub 2015 May 9.

29.

Multidrug-resistant Gram-negative bacteria: a product of globalization.

Hawkey PM.

J Hosp Infect. 2015 Apr;89(4):241-7. doi: 10.1016/j.jhin.2015.01.008. Epub 2015 Feb 4. Review.

PMID:
25737092
30.

Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.

Ironmonger D, Edeghere O, Bains A, Loy R, Woodford N, Hawkey PM.

J Antimicrob Chemother. 2015;70(6):1744-50. doi: 10.1093/jac/dkv043. Epub 2015 Mar 1.

PMID:
25733586
31.

The hidden resistome of retail chicken meat.

Amos GC, Carter A, Hawkey PM, Gaze WH, Wellington EM.

J Glob Antimicrob Resist. 2015 Mar;3(1):44-46. doi: 10.1016/j.jgar.2014.11.003. Epub 2015 Jan 14. No abstract available.

PMID:
27873650
32.

Tuberculosis microepidemics among dispersed migrants, Birmingham, UK, 2004-2013.

Munang ML, Browne C, Khanom S, Evans JT, Smith EG, Hawkey PM, Kunst H, Welch SB, Dedicoat MJ.

Emerg Infect Dis. 2015 Mar;21(3):524-7. doi: 10.3201/eid2103.140209.

33.

Validated predictive modelling of the environmental resistome.

Amos GC, Gozzard E, Carter CE, Mead A, Bowes MJ, Hawkey PM, Zhang L, Singer AC, Gaze WH, Wellington EM.

ISME J. 2015 Jun;9(6):1467-76. doi: 10.1038/ismej.2014.237. Epub 2015 Feb 13.

34.

Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment.

Amos GC, Hawkey PM, Gaze WH, Wellington EM.

J Antimicrob Chemother. 2014 Jul;69(7):1785-91. doi: 10.1093/jac/dku079. Epub 2014 May 5.

35.

How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

Szczepura A, Manzoor S, Hardy K, Stallard N, Parsons H, Gossain S, Hawkey PM.

BMC Infect Dis. 2014 Mar 21;14:154. doi: 10.1186/1471-2334-14-154.

36.

Functional metagenomic analysis reveals rivers are a reservoir for diverse antibiotic resistance genes.

Amos GC, Zhang L, Hawkey PM, Gaze WH, Wellington EM.

Vet Microbiol. 2014 Jul 16;171(3-4):441-7. doi: 10.1016/j.vetmic.2014.02.017. Epub 2014 Feb 16.

37.

Faecal transplantation for the treatment of Clostridium difficile infection: a review.

McCune VL, Struthers JK, Hawkey PM.

Int J Antimicrob Agents. 2014 Mar;43(3):201-6. doi: 10.1016/j.ijantimicag.2013.10.009. Epub 2013 Nov 9. Review.

PMID:
24636428
38.

Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia?

Hawkey PM, Marriott C, Liu WE, Jian ZJ, Gao Q, Ling TK, Chow V, So E, Chan R, Hardy K, Xu L, Manzoor S.

J Clin Microbiol. 2013 Oct;51(10):3308-13. doi: 10.1128/JCM.00587-13. Epub 2013 Jul 31.

39.

Epidemiology of Clostridium difficile infection in Asia.

Collins DA, Hawkey PM, Riley TV.

Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21.

40.

Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Hingley-Wilson SM, Casey R, Connell D, Bremang S, Evans JT, Hawkey PM, Smith GE, Jepson A, Philip S, Kon OM, Lalvani A.

Emerg Infect Dis. 2013 Jul;19(7):1138-41. doi: 10.3201/1907.130313.

41.

AmWeb: a novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients.

Ironmonger D, Edeghere O, Gossain S, Bains A, Hawkey PM.

J Antimicrob Chemother. 2013 Oct;68(10):2406-13. doi: 10.1093/jac/dkt181. Epub 2013 May 17.

PMID:
23687187
42.

UK antimicrobial resistance strategy must be set in a wider context.

Hawkey PM, Patel BC, Trees AJ.

BMJ. 2013 May 15;346:f2999. doi: 10.1136/bmj.f2999. No abstract available.

PMID:
23678076
43.

The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria.

Wellington EM, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, Johnson-Rollings AS, Jones DL, Lee NM, Otten W, Thomas CM, Williams AP.

Lancet Infect Dis. 2013 Feb;13(2):155-65. doi: 10.1016/S1473-3099(12)70317-1. Review.

PMID:
23347633
44.

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.

Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, Eyre DW, Wilson DJ, Hawkey PM, Crook DW, Parkhill J, Harris D, Walker AS, Bowden R, Monk P, Smith EG, Peto TE.

Lancet Infect Dis. 2013 Feb;13(2):137-46. doi: 10.1016/S1473-3099(12)70277-3. Epub 2012 Nov 15.

45.

Utilizing rapid multiple-locus variable-number tandem-repeat analysis typing to aid control of hospital-acquired Clostridium difficile Infection: a multicenter study.

Hardy K, Manzoor S, Marriott C, Parsons H, Waddington C, Gossain S, Szczepura A, Stallard N, Hawkey PM.

J Clin Microbiol. 2012 Oct;50(10):3244-8. doi: 10.1128/JCM.00784-12. Epub 2012 Jul 25.

46.

Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China.

Jiang HX, Tang D, Liu YH, Zhang XH, Zeng ZL, Xu L, Hawkey PM.

J Antimicrob Chemother. 2012 Oct;67(10):2350-3. doi: 10.1093/jac/dks250. Epub 2012 Jul 18.

PMID:
22809702
47.

Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW.

Clin Infect Dis. 2012 Oct;55(8):1056-63. Epub 2012 Jul 11.

PMID:
22784871
48.

Carbapenem antibiotics for serious infections.

Hawkey PM, Livermore DM.

BMJ. 2012 May 31;344:e3236. doi: 10.1136/bmj.e3236. No abstract available.

PMID:
22654063
49.

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

Livermore DM, Andrews JM, Hawkey PM, Ho PL, Keness Y, Doi Y, Paterson D, Woodford N.

J Antimicrob Chemother. 2012 Jul;67(7):1569-77. doi: 10.1093/jac/dks088. Epub 2012 Mar 29. Review.

PMID:
22461311
50.

High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK.

Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, Hawkey PM.

J Antimicrob Chemother. 2012 May;67(5):1108-13. doi: 10.1093/jac/dks018. Epub 2012 Mar 8.

PMID:
22403261

Supplemental Content

Loading ...
Support Center